
Cenk Ural
Address: Bagcilar Education And Research Hospital, Department of Psychiatry, istanbul, Turkey
less
Related Authors
Matthew Broome
University of Oxford
Matthew Ratcliffe
University of York
John Sutton
Macquarie University
Keith Laws
University of Hertfordshire
Lirieka Meintjes-van Der Walt
University of Fort Hare
John Danaher
University of Galway
Kirk Schneider
Saybrook University
Kelly G . Wilson
University of Mississippi
Jakob Tanner
University of Zurich, Switzerland
Eduard Rats
Independent Researcher
Uploads
Papers by Cenk Ural
The relationship between Panic Disorder (PD) and dissociation is well known. In this study we aimed to investigate whether or not dissociative experiences affect the response to PD drug treatment. For this purpose, standart dose of venlafaxine was preferred for treatment. 63 patients with PD were included in the study. Venlafaxine treatment with increasing dose was administered to each patient during a 10-week period. The Panic Disorder Severity Scale (PDSS) and the Dissociation Questionnaire (DIS-Q) were applied to the patients at the
beginning of the study. Patients were divided into two groups based on DIS-Q scores. PDSS was applied again to both groups at the end of 10-week treatment. No difference between sociodemographic data and PDSS scores of two groups – patients with low DIS-Q scores (b2.5) and high DIS-Q scores (N2.5) – was found at the beginning. At the end of the study, a significant decrease in PDSS scores measured in both groups was detected. However, the decrease in PDSS score for the group with lower DIS-Q score was at a higher percentage (z = −3.822, p = 0.0001). These results depict that dissociative symptoms accompanying PD affect psychopharmacological treatment in a negative way. Reevaluation of dissociative symptoms at the beginning and end of treatment would help in planning personal therapy.
All patients admitted for the first time to the psychiatric outpatient unit were included in the study. Seventy-eight patients had been diagnosed as having OCD during the 2-year study period. Patients had to meet the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for OCD. Most (76.9%; n = 60) of the patients were female, and 23.1% (n = 18) of the patients were male. Dissociation Questionnaire was used to measure dissociative symptoms. The Structured Clinical Interview for Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition Dissociative Disorders interviews and Yale-Brown Obsessive Compulsive Checklist and Severity Scale were used. Eleven (14%) of the patients with OCD had comorbid dissociative disorder. The most prevalent disorder in our study was dissociative depersonalization disorder. Dissociative amnesia and dissociative identity disorder were common as
well. The mean Yale-Brown score was 23.37 ± 7.27 points. Dissociation Questionnaire scores were between 0.40 and 3.87 points, and the mean was 2.23 ± 0.76 points. There was a statistically significant positive correlation between Yale-Brown points and Dissociation Questionnaire points. We conclude that dissociative symptoms among patients with OCD should alert clinicians for the presence of a chronic and complex
dissociative disorder. Clinicians may overlook an underlying dissociative process in patients who have severe symptoms of OCD. However, a lack of adequate response to cognitive-behavioral and drug therapy may be a consequence of dissociative process.
CONCLUSION:
Assessment of detailed psychopathological aspects and psychiatric co-morbidities could help to define the clinical profile of people requesting cosmetic rhinoplasty in cosmetic surgery settings. Research into these factors may be important as it is essential to detect crucial problems such as personality disorders and BDD before surgery.
psychopathologic symptoms are quite limited. Research has shown that psychopathologic evaluation conducted preoperatively is especially important to identify serious psychopathologies such as personality disorders and body dysmorphic disorder (BDD).
Conclusions: Exclusion of patients possessing serious psychopathologies from operations provides better results in the long term. The lack of sufficient research in this area necessitates new and comprehensive studies.
Methods: Total of 463 patients (329 males and 134 females) hospitalized with the diagnosis of schizophrenia according to DSM-IV criteria and who were between 15-65 years of age were included in the study. We evaluated the age, gender, marital status, number of children, onset of the disease and subtype of schizophrenia.
Results: Mean of onset of the disease score was higher statistically in the females (27.6 ± 4.3) than the males (23.7 ± 3.9) (p < 0.05) in our study. The paranoid subtype was the commonest, while women were more likely to be married than men, men had more children than women; and the paranoid subtype were more likely to be married than the other groups.
Conclusions: Onset age of schizophrenia was four years higher in the women than in men and that the rates of the schizophrenia subtypes were consistent with those detected in the other studies demonstrates that these rates were determined by neurobiological mechanisms rather than socio-cultural factors.
Method: For this purpose, the psychiatry literature was comprehensively reviewed. A screening of the articles in the international databases covering the period between 1970 and 2010 was performed.
Results: Although the risk of homicidal behaviours is higher in patients with schizophrenia compared to the overall population, little is known about the relevant conditions triggering acts of violence among the patients with schizophrenia. The available results suggest that certain factors including some sociodemographic characteristics, young age, alcoholism, substance abuse, noncompliance with treatment, fulfillment of the criteria for antisocial personality disorder and paranoid subtype, history of suicidal ideation and attempts and history of frequent hospitalization increase the potential for violent episodes.
Available data show clozapine to be the most rational therapeutic choice in preventing violent behaviour in patients with schizophrenia. There is evidence from randomized controlled trials in support of the specific anti-aggressive effect of clozapine.
Conclusion: In clinical practice, patients with a risk of committing homicide should be detected and monitored closely. There are many trials showing the efficacy of clozapine on violent and aggressive behaviour.
Schizophrenia, violence and homicidal act: assessing the risks, preventive measures and
place of clozapine in the treatment
Objective: This review is designed to analyze the potential risk factors and preventive measures involved
in homicidal behaviors in schizophrenic individuals and investigate the efficacy of clozapine in preventing
these violence behaviors and evaluate the results.
Method: For this purpose, the psychiatry literature was comprehensively reviewed. A screening of the
articles in the international and national databases, covering the period between 1979 and 2010 was
performed. Trials that have contributed to this field were also utilized.
Results: Although the risk of homicidal behaviors is higher in the schizophrenic individuals compared to the
overall population, little is known about the relevant conditions triggering this act of violence among
criminals. The available results suggest that certain factors, including some socio-demographic characteristics,
male gender, young age, alcoholism, substance abuse, incompliance with the treatment, fulfillment of the
criteria for antisocial personality disorder and paranoid subtype, history of suicidal ideation and attempts,
and history of frequent hospitalization increase the probability for occurrence of violent episodes.
Conclusion: In the clinical practice, the patients with a risk of committing homicide should be detected and
monitored closely. The available data show clozapine to be the most rational therapeutic choice in
preventing the acts of violence in schizophrenics.
Key words: Schizophrenia, violence, homicide, risk factors, preventive measures, clozapine
Method: Psychiatric literature was scanned for this purpose. All articles written 1970 to 2010 in the scientific database were reviewed.
Discussion: It has been already known for a long time that completed or triled suicide attempt rates are high among patients having a diagnosis of schizophrenia. High risk is associated with male sex, previous suicide attempts, depressive symptoms, early stages of disease, high frequency of hospitalization, premorbid social malfunction, abuse and traumatic experiences in childhood and a family history of suicide. These are predisposing factors which should be regarded. It is also known that the period following discharge from hospital is particularly risky, since frequency of suicide attempts are increased in this period. Present data shows that clozapine is the best choice of treatment to prevent suicide directed behavior in schizophrenics.
However other atypical antipsychotics like olanzapine, risperidone, amisulpride, ziprasidone and aripiprazole are also known to be a choice of treatment.
Conclusion: Patients with a suicide risk should be determined and followed closely and frequently in clinical practice.
Subjects and Method: The participants were recruited from patients who were attending internal medicine and gastroenterology clinics and who fullfilled the Rome III criteria for IBS. Fifty patients with IBS (IBS group) and 50 patients with complaints other than gastrointestinal symptoms (control
group) were randomly selected. All participants were screened by the Structured Clinical Interview for DSM-IV (SCID-I), Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Symptom Check list – 90 (Revised) [SCL-90-R].
Results: Seventeen patients (34%) and three control subjects (6%) had at least one psychiatric diagnosis (p = 0.001). Global severity index (GSI) total scores and SCL-90-R items were significantly higher in the IBS group than the control group (0.92 ± 0.46 vs 0.358 ± 0.19, p < 0.001). Beck anxiety inventory and BDI scores were higher in the IBS group than the control group (p < 0.001). Axis-I psychiatric disorders diagnosed with SCID-I were significantly higher in the IBS group (34% vs 6%) [p = 0.001].
Among the Axis-I disorders, somatoform and anxiety disorders were higher in the patient group than in the control subjects (p = 0.002 and p = 0.0057) whereas there was no difference for mood disorders (p = 0.204). Seven (14%) of the patients and two (4%) of the control subjects had at least one Axis-II psychiatric disorder diagnosed with SCID-II without any significance (p = 0.159).
Conclusion: These findings suggest that except for mood and personality disorders, almost all psychiatric symptoms and disease co-morbities with IBS are higher than in the sample without IBS. We can easily use SCL-90-R, BAI and BDI in internal medicine and gastroenterology clinics to detect psychiatric symptom levels and then to refer patients to a psychiatrist for further evaluation and treatment.
criminal behavior of schizophrenic patients.
Method: Schizophrenic (according to DSM-IV) patients (66 from the general psychiatry units and 69 from
forensic psychiatry clinics) participated in the research from a regional hospital in the northwest of Turkey.
Forensic psychiatric patients are divided into two subgroups, namely those who migrated (n=30) within the
country and not (n=39), with those who are repetitive offenders (n=29) and not (n=40); then groups were
compared in the point of parameters of crime and migration.
Results: Most of the patients who have not committed a crime were from cities. Even though there was
no significant difference, with those who have committed a crime, the age of internal migration was
younger. Migration raised the possibility of the recidivism of the criminal acts up to 5 fold whereas, having
already been prisoned before raised this possibility up to 17 fold and childhood within the criminal group.
Conclusions: Although our data indicated the internal migration not to affect the rate of the criminal acts
among the patients with schizophrenia meaningfully, it significantly affected repetition of crime within the
criminal group. The need to focus on internal migration and urbanization as disruptive environmental
conditions effecting schizophrenia and crime in countries like Turkey where the urbanization process is still
ongoing, is obvious.
Key words: Crime, internal migration, schizophrenia
Both disorders can show common features in terms of diagnosis and overlap in phenomenological perspective. Coexistence of both disorders is quite frequent. The nature of mood shifts, types of impulsivity and the longitudinal course of the disorders should be considered to differenciate them. There are findings on the effectiveness of mood stabilizers such as lithium, carbamazepine, oxcarbazepine, sodium valproate or lamotrigine in the treatment of the borderline personality disorder. The differentiation of borderline personality disorder from bipolar disorder is not easy. A very careful evaluation is required. This differentiation may also be useful in terms of treatment. A greater number of research results are available on the effectiveness of valproate and lamotrigine in the treatment of borderline personality disorder. Findings related to other mood stabilizers are insufficient. In
the treatment of borderline personality disorder, there is not any drug approved by the official authorities. Psychotherapeutic approaches still retain their important place in the treatment. However, symptombased approach is proposed in the use of mood stabilizers.
The relationship between Panic Disorder (PD) and dissociation is well known. In this study we aimed to investigate whether or not dissociative experiences affect the response to PD drug treatment. For this purpose, standart dose of venlafaxine was preferred for treatment. 63 patients with PD were included in the study. Venlafaxine treatment with increasing dose was administered to each patient during a 10-week period. The Panic Disorder Severity Scale (PDSS) and the Dissociation Questionnaire (DIS-Q) were applied to the patients at the
beginning of the study. Patients were divided into two groups based on DIS-Q scores. PDSS was applied again to both groups at the end of 10-week treatment. No difference between sociodemographic data and PDSS scores of two groups – patients with low DIS-Q scores (b2.5) and high DIS-Q scores (N2.5) – was found at the beginning. At the end of the study, a significant decrease in PDSS scores measured in both groups was detected. However, the decrease in PDSS score for the group with lower DIS-Q score was at a higher percentage (z = −3.822, p = 0.0001). These results depict that dissociative symptoms accompanying PD affect psychopharmacological treatment in a negative way. Reevaluation of dissociative symptoms at the beginning and end of treatment would help in planning personal therapy.
All patients admitted for the first time to the psychiatric outpatient unit were included in the study. Seventy-eight patients had been diagnosed as having OCD during the 2-year study period. Patients had to meet the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for OCD. Most (76.9%; n = 60) of the patients were female, and 23.1% (n = 18) of the patients were male. Dissociation Questionnaire was used to measure dissociative symptoms. The Structured Clinical Interview for Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition Dissociative Disorders interviews and Yale-Brown Obsessive Compulsive Checklist and Severity Scale were used. Eleven (14%) of the patients with OCD had comorbid dissociative disorder. The most prevalent disorder in our study was dissociative depersonalization disorder. Dissociative amnesia and dissociative identity disorder were common as
well. The mean Yale-Brown score was 23.37 ± 7.27 points. Dissociation Questionnaire scores were between 0.40 and 3.87 points, and the mean was 2.23 ± 0.76 points. There was a statistically significant positive correlation between Yale-Brown points and Dissociation Questionnaire points. We conclude that dissociative symptoms among patients with OCD should alert clinicians for the presence of a chronic and complex
dissociative disorder. Clinicians may overlook an underlying dissociative process in patients who have severe symptoms of OCD. However, a lack of adequate response to cognitive-behavioral and drug therapy may be a consequence of dissociative process.
CONCLUSION:
Assessment of detailed psychopathological aspects and psychiatric co-morbidities could help to define the clinical profile of people requesting cosmetic rhinoplasty in cosmetic surgery settings. Research into these factors may be important as it is essential to detect crucial problems such as personality disorders and BDD before surgery.
psychopathologic symptoms are quite limited. Research has shown that psychopathologic evaluation conducted preoperatively is especially important to identify serious psychopathologies such as personality disorders and body dysmorphic disorder (BDD).
Conclusions: Exclusion of patients possessing serious psychopathologies from operations provides better results in the long term. The lack of sufficient research in this area necessitates new and comprehensive studies.
Methods: Total of 463 patients (329 males and 134 females) hospitalized with the diagnosis of schizophrenia according to DSM-IV criteria and who were between 15-65 years of age were included in the study. We evaluated the age, gender, marital status, number of children, onset of the disease and subtype of schizophrenia.
Results: Mean of onset of the disease score was higher statistically in the females (27.6 ± 4.3) than the males (23.7 ± 3.9) (p < 0.05) in our study. The paranoid subtype was the commonest, while women were more likely to be married than men, men had more children than women; and the paranoid subtype were more likely to be married than the other groups.
Conclusions: Onset age of schizophrenia was four years higher in the women than in men and that the rates of the schizophrenia subtypes were consistent with those detected in the other studies demonstrates that these rates were determined by neurobiological mechanisms rather than socio-cultural factors.
Method: For this purpose, the psychiatry literature was comprehensively reviewed. A screening of the articles in the international databases covering the period between 1970 and 2010 was performed.
Results: Although the risk of homicidal behaviours is higher in patients with schizophrenia compared to the overall population, little is known about the relevant conditions triggering acts of violence among the patients with schizophrenia. The available results suggest that certain factors including some sociodemographic characteristics, young age, alcoholism, substance abuse, noncompliance with treatment, fulfillment of the criteria for antisocial personality disorder and paranoid subtype, history of suicidal ideation and attempts and history of frequent hospitalization increase the potential for violent episodes.
Available data show clozapine to be the most rational therapeutic choice in preventing violent behaviour in patients with schizophrenia. There is evidence from randomized controlled trials in support of the specific anti-aggressive effect of clozapine.
Conclusion: In clinical practice, patients with a risk of committing homicide should be detected and monitored closely. There are many trials showing the efficacy of clozapine on violent and aggressive behaviour.
Schizophrenia, violence and homicidal act: assessing the risks, preventive measures and
place of clozapine in the treatment
Objective: This review is designed to analyze the potential risk factors and preventive measures involved
in homicidal behaviors in schizophrenic individuals and investigate the efficacy of clozapine in preventing
these violence behaviors and evaluate the results.
Method: For this purpose, the psychiatry literature was comprehensively reviewed. A screening of the
articles in the international and national databases, covering the period between 1979 and 2010 was
performed. Trials that have contributed to this field were also utilized.
Results: Although the risk of homicidal behaviors is higher in the schizophrenic individuals compared to the
overall population, little is known about the relevant conditions triggering this act of violence among
criminals. The available results suggest that certain factors, including some socio-demographic characteristics,
male gender, young age, alcoholism, substance abuse, incompliance with the treatment, fulfillment of the
criteria for antisocial personality disorder and paranoid subtype, history of suicidal ideation and attempts,
and history of frequent hospitalization increase the probability for occurrence of violent episodes.
Conclusion: In the clinical practice, the patients with a risk of committing homicide should be detected and
monitored closely. The available data show clozapine to be the most rational therapeutic choice in
preventing the acts of violence in schizophrenics.
Key words: Schizophrenia, violence, homicide, risk factors, preventive measures, clozapine
Method: Psychiatric literature was scanned for this purpose. All articles written 1970 to 2010 in the scientific database were reviewed.
Discussion: It has been already known for a long time that completed or triled suicide attempt rates are high among patients having a diagnosis of schizophrenia. High risk is associated with male sex, previous suicide attempts, depressive symptoms, early stages of disease, high frequency of hospitalization, premorbid social malfunction, abuse and traumatic experiences in childhood and a family history of suicide. These are predisposing factors which should be regarded. It is also known that the period following discharge from hospital is particularly risky, since frequency of suicide attempts are increased in this period. Present data shows that clozapine is the best choice of treatment to prevent suicide directed behavior in schizophrenics.
However other atypical antipsychotics like olanzapine, risperidone, amisulpride, ziprasidone and aripiprazole are also known to be a choice of treatment.
Conclusion: Patients with a suicide risk should be determined and followed closely and frequently in clinical practice.
Subjects and Method: The participants were recruited from patients who were attending internal medicine and gastroenterology clinics and who fullfilled the Rome III criteria for IBS. Fifty patients with IBS (IBS group) and 50 patients with complaints other than gastrointestinal symptoms (control
group) were randomly selected. All participants were screened by the Structured Clinical Interview for DSM-IV (SCID-I), Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Symptom Check list – 90 (Revised) [SCL-90-R].
Results: Seventeen patients (34%) and three control subjects (6%) had at least one psychiatric diagnosis (p = 0.001). Global severity index (GSI) total scores and SCL-90-R items were significantly higher in the IBS group than the control group (0.92 ± 0.46 vs 0.358 ± 0.19, p < 0.001). Beck anxiety inventory and BDI scores were higher in the IBS group than the control group (p < 0.001). Axis-I psychiatric disorders diagnosed with SCID-I were significantly higher in the IBS group (34% vs 6%) [p = 0.001].
Among the Axis-I disorders, somatoform and anxiety disorders were higher in the patient group than in the control subjects (p = 0.002 and p = 0.0057) whereas there was no difference for mood disorders (p = 0.204). Seven (14%) of the patients and two (4%) of the control subjects had at least one Axis-II psychiatric disorder diagnosed with SCID-II without any significance (p = 0.159).
Conclusion: These findings suggest that except for mood and personality disorders, almost all psychiatric symptoms and disease co-morbities with IBS are higher than in the sample without IBS. We can easily use SCL-90-R, BAI and BDI in internal medicine and gastroenterology clinics to detect psychiatric symptom levels and then to refer patients to a psychiatrist for further evaluation and treatment.
criminal behavior of schizophrenic patients.
Method: Schizophrenic (according to DSM-IV) patients (66 from the general psychiatry units and 69 from
forensic psychiatry clinics) participated in the research from a regional hospital in the northwest of Turkey.
Forensic psychiatric patients are divided into two subgroups, namely those who migrated (n=30) within the
country and not (n=39), with those who are repetitive offenders (n=29) and not (n=40); then groups were
compared in the point of parameters of crime and migration.
Results: Most of the patients who have not committed a crime were from cities. Even though there was
no significant difference, with those who have committed a crime, the age of internal migration was
younger. Migration raised the possibility of the recidivism of the criminal acts up to 5 fold whereas, having
already been prisoned before raised this possibility up to 17 fold and childhood within the criminal group.
Conclusions: Although our data indicated the internal migration not to affect the rate of the criminal acts
among the patients with schizophrenia meaningfully, it significantly affected repetition of crime within the
criminal group. The need to focus on internal migration and urbanization as disruptive environmental
conditions effecting schizophrenia and crime in countries like Turkey where the urbanization process is still
ongoing, is obvious.
Key words: Crime, internal migration, schizophrenia
Both disorders can show common features in terms of diagnosis and overlap in phenomenological perspective. Coexistence of both disorders is quite frequent. The nature of mood shifts, types of impulsivity and the longitudinal course of the disorders should be considered to differenciate them. There are findings on the effectiveness of mood stabilizers such as lithium, carbamazepine, oxcarbazepine, sodium valproate or lamotrigine in the treatment of the borderline personality disorder. The differentiation of borderline personality disorder from bipolar disorder is not easy. A very careful evaluation is required. This differentiation may also be useful in terms of treatment. A greater number of research results are available on the effectiveness of valproate and lamotrigine in the treatment of borderline personality disorder. Findings related to other mood stabilizers are insufficient. In
the treatment of borderline personality disorder, there is not any drug approved by the official authorities. Psychotherapeutic approaches still retain their important place in the treatment. However, symptombased approach is proposed in the use of mood stabilizers.